Materials characterisation company Malvern Instruments Ltd has signed an exclusive distribution agreement with Affinity Biosensors LLC which will extend the range of solutions that Malvern offers to the biopharmaceutical sector.The ...
Tags: Malvern Instruments Ltd, Affinity Biosensors LLC, biopharmaceutical
Soil pollution is defined as the build-up in soils of persistent toxic compounds, chemicals, salts, radioactive materials, or disease causing agents, which have adverse effects on plant growth and animal health. The wars that hit the ...
Tags: Glass Industry, Soil Pollution, persistent toxic compounds, chemicals
LGC Standards’ LoGiCal reference solutions are proving beneficial to the Eastern Finland Laboratory Centre Joint Authority Enterprise (ISLAB) laboratory at Kuopio University Hospital. ISLAB performs around eight million analyses ...
Tags: LGC Standards, healthcare
Scientists funded by Cancer Research UK are using virtual experiments in a bid to find the best methods for drug discovery. The findings have been published in the Nature Reviews Drug Discovery journal, with the work combining a unique ...
Tags: Cancer Research UK, virtual experiments, drug discovery, online database
Bio-AMD's majority owned medical devices subsidiary, Bio AMD Limited has submitted a patent application for an Immunoassay Result Reading Apparatus (IRRA) at UK Intellectual Property Office. The IRRA technology can be applied to any ...
Tags: medical devices, Bio AMD Limited, IRRA, UK
Depomed's lawsuits against Watson Laboratories and Par Pharmaceutical in relation to Abbreviated New Drug Applications (ANDAs) for Gralise (gabapentin) have been dismissed. The company said that both the companies no longer sought ...
Tags: Depomed, Watson Laboratories, Par Pharmaceutical, lawsuit
Fugitive antivirus pioneer John McAfee could soon be released from detention in Guatemala where he is being held on charges that he entered the country illegally in an attempt to escape authorities in Belize where he is wanted for ...
Tags: McAfee, Antivirus software, software, McAfee software
One day, pharmaceutical companies might not have to test new drugs on animals or even humans. Instead, drugs could be tested with organ-on-a-chip technologies. These are not silicon chips that simulate organs or organisms, mind you; they ...
Tags: Organs, Chip, Harvard, Human Body, Silicon
Silent Partner Technologies (SPT) and Equipment Management Service And Repair (EMSAR) Inc, leaders in their respective fields have partnered to offer state of the art RFID based Asset Visibility/Asset Management solutions. Silent Partner ...
Tags: RFID Asset, EMS Companies, Computer Products
QLT has signed an exclusive option agreement with Mati Therapeutics, granting it a 90-day option to acquire assets related to QLT's punctal plug drug delivery system (PPDS) technology for $500,000. The agreement will allow the company ...
Tags: QLT, Mati Therapeutics, PPDS technology, agreement
1. How to get permanent residence permit? You should submit: (a) Valid passport or equivalent; (b) Health certi_ cate issued at state level; (c) Credentials proving no criminal record by China embassies or consulates; (d) Two passport ...
Tags: Focus Vision, China, Living in China
The Fourth Amendment protects Americans from unlawful searches and seizures. Among other things, this means that if law enforcement suspects someone of a crime, they need a probable-cause warrant before they can search a person's home, car ...
Tags: Fourth Amendment, law enforcement, cuber security, network
US-based Blend Therapeutics has appointed Mark Iwicki as its president, chief executive officer and a member of the board of directors. Iwicki comes with more than 23 years of experience in the pharmaceutical industry with experience in ...
Tags: Blend Therapeutics, CEO, Iwicki, drug development
A new study by UCLA has discovered that study partners play a key role in clinical trials for Alzheimer's disease. These people provide patients with support while updating researchers about progress, with the new research finding how a ...
Tags: Instruments, Meters, disease trials, UCLA
Lexicon Pharmaceuticals has won Fast Track status from the US FDA to develop LX1033, an orally-delivered small molecule drug candidate to treat diarrhea-predominant irritable bowel syndrome (IBS-d). Fast Track facilitates the development ...
Tags: Lexicon Pharmaceuticals, small molecule drug candidate